Antitumor effect and pharmacokinetics of intraperitoneal NK105, a nanomicellar paclitaxel for peritoneal dissemination
Cancer Science, 03/21/2012
Clinical Article
Emoto S et al. – Intraperitoneal chemotherapy with nanoparticulate paclitaxel NK105 may offer a novel treatment strategy for improving drug delivery in gastric cancer with peritoneal dissemination because of enhanced drug penetration into peritoneal nodules and prolonged systemic circulation.



